At a Glance
Johnson & Johnson Innovation - JJDC is a venture capital firm based in Menlo Park, CA founded in 1973. Healthcare innovation wherever it originates. The firm focuses on Series A, Series B+ investments across sectors including Digital Health, Biotech, AI. The firm manages $3B in assets under management. Notable portfolio companies include Verb Surgical, Veracyte, Auris Health, Legend Biotech, Actelion, Synthes, Momenta and SpringWorks. Investing in revolutionary healthcare companies that have the potential to profoundly change the trajectory of health for humanity.
“Investing in revolutionary healthcare companies that have the potential to profoundly change the trajectory of health for humanity.”
Johnson & Johnson Innovation - JJDC primarily invests at the Series A, Series B+ stages. This means they focus on companies that are scaling their go-to-market after proving product-market fit.
Johnson & Johnson Innovation - JJDC is headquartered in Menlo Park, CA. Many of their portfolio companies are also based in this region, though they invest across geographies.
Johnson & Johnson Innovation - JJDC focuses on investments in Digital Health, Biotech, AI. Their portfolio reflects deep expertise and networks within these sectors.
Johnson & Johnson Innovation - JJDC's typical investment check size ranges from $3M to $75M. Actual amounts may vary based on the stage, sector, and specific opportunity.
Johnson & Johnson Innovation - JJDC manages approximately $3B in assets under management (AUM) across their funds.
